CytoImmune Therapeutics, Inc.
Biotechnology company · Monrovia, California, United States
CytoImmune Therapeutics, Inc. is a biotechnology company headquartered in Monrovia, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $37 million sold in a notice filed in 2021.
CytoImmune Therapeutics at a glance
What does CytoImmune Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $36.5 million sold (2021).
Frequently asked questions about CytoImmune Therapeutics
Where is CytoImmune Therapeutics headquartered?
CytoImmune Therapeutics, Inc. is headquartered in Monrovia, California, United States.
What does CytoImmune Therapeutics do?
CytoImmune Therapeutics, Inc. is a biotechnology company.
When was CytoImmune Therapeutics founded?
The earliest incorporation on record for CytoImmune Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Exozymes Inc.Monrovia, California, United States
- Chromologic LLCMonrovia, California, United States
- Pace Diagnostics, Inc.Monrovia, California, United States
- Immunova Therapeutics LLCMonrovia, California, United States
- Immunowork LLCMonrovia, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences